Antibody to platelet/endothelial cell adhesion molecule-1 reduces myocardial infarct size in a rat model of ischemia-reperfusion injury

Circulation

Volumn 94, Issue 12, 1996, Pages 3327-3333

  Gumina, Richard J ^a,e   Schultz, Jo El ^b   Yao, Zhenhai ^b   Kenny, Dermot ^d,e   Warltier, David C ^b,c,d   Newman, Peter J ^a,b,e   Gross, Garrett J ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Departments of Pharmacology   (United States)

^c Departments of Anesthesiology

^d Departments of Medicine

^e BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

endothelium; ischemia; leukocytes; myocardial infarction; reperfusion

Indexed keywords

CD31 ANTIGEN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G; POLYCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; ENZYME ACTIVITY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ADHERENCE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; THROMBOCYTE ADHESION;

EID: 0030453794     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.12.3327     Document Type: Article

References (61)

1. Newman PJ, Berndt MC, Gorski J, White GC, Lyman S, Paddock C, Muller WA. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science. 1990;247: 1290-1292.
2. Albelda SM, Muller WA, Buck CA, Newman PJ. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol. 1991;114:1059-1068.
3. Newman PJ. The role of PECAM-1 in vascular cell biology. Ann N Y Acad Sci. 1994;714:165-174.
4. DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today. 1994;15:490-495.
5. DeLisser HM, Van HC, Newman PJ, Muller WA, Buck CA, Albelda SM. Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans. J Biol Chem. 1993;268:16037-16046.
6. DeLisser HM, Chilkotowsky J, Van HC, Daise ML, Buck CA, Albelda SM. Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) result in changes in ligand binding properties. J Cell Biol. 1994;124:195-203.
7. Albelda SM, Oliver PD, Romer LH, Buck CA. EndoCAM: a novel endothelial cell-cell adhesion molecule. J Cell Biol. 1990;110:1227-1237.
8. Ohto H, Maeda H, Shibata Y, Chen R-F, Ozaki Y, Higashihara M, Takeuchi A, Tohyama H. A novel leukocyte differentiation antigen: two monoclonal antibodies TM2 and TM3 define a 120-kd molecule present on neutrophils. monocytes. platelets, and activated lymphoblasts. Blond. 1985;66:873-881.
9. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendolhelial migration of leukocytes. J Exp Med. 1993;178:449-460.
10. Vaporciyan AA, DeLisser HM, Yan HC, Mendiguren II, Thom SR, Jones ML, Ward PA, Albelda SM. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science. 1993;262:1580-1582.
11. Bogen S, Pak J, Garifallou M, Deng X, Muller WA. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med. 1994;179:1059-1064.
12. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994;8:504-512.
13. Carlos TM, Harlan JM. Leukocyte-endothelial cell adhesion molecules. Blood. 1994;84:2069-2101.
14. Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol. 1995;57:827-872.
15. Moore KL, Stults ML, Diaz S, Smith DF, Cummings RD, Varki A, McEver RP. Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol. 1992;118:445-456.
16. Moore KL, Patel KD, Bruehl RE, Li F, Johnson DA, Lichenstein HS, Cummings RD, Bainton DF, McEver RP. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol. 1995;128:661-671.
17. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 1991;65:859-873.
18. Diamond MS, Staunton DE, de Fougerolles AR, Stacker SA, Garcia-Aguilar J, Hibbs ML, Springer TA. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD1 lb/CD18). J Cell Biol. 1990;111:3129-3139.
19. von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors KE, Butcher EC. Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. Proc Natl Acad Sci USA. 1991; 88:7538-7542.
20. Smith CW, Rothlein R, Hughes BJ, Mariscalco MM, Rudloff HE, Schmalstieg FC, Anderson DC. Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendolhelial migration. J Clin Invest. 1988;82:1746-1756.
21. Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC. Cooperative interactions of LFA-) and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest. 1989;83: 2008-2017.
22. Smith CW. Molecular determinants of neutrophil adhesion. Am J Respir Cell Mol Biol. 1990;2:487-489.
23. Hearse DJ, Bolli R. Reperfusion injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res. 1992;26:101-108.
24. Engler RL, Dahlgren MD, Morris DD, Peterson MA, Schmid-Schonbein GW. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol. 1986;251:H314-H323.
25. Entman ML, Michael L, Rossen RD, Dreyer WJ, Anderson DC, Taylor AA, Smith CW. Inflammation in the course of early myocardial ischemia. FASEB J. 1991;5:2529-2537.
26. Entman ML, Smith CW. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res. 1994; 28:1301-1311.
27. Weyrich AS, Ma X, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest. 1993;91: 2620-2629.
28. Ma X, Weyrich AS, Lefer DJ, Buerke M, Albertine KH, Kishimoto TK, Lefer AM. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation. 1993;88:649-658.
29. Buerke M, Weyrich AS, Zheng Z, Gaeta FCA, Forrest MJ, Lefer AM. Sialyl Lewis-x-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J Clin Invest. 1994;93:1140-1148.
30. Murohara T, Beurke M, Lefer AM. Polymorphonuclear leukocyte-induced vasoconstriction and endothelial dysfunction. Arterioscler Thromb. 1994;14:1509-1519.
31. Simpson PJ, Todd RF III, Fantone JC, Mickelson JK, Griffin JD, Lucchesi BR. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo-1, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest. 1988;81:624-629.
32. Yamazaki T, Seko Y, Tamatami T, Miyasaka M, Yagita H, Okumura K, Nagai R, Yazaki Y. Expression of intercellular adhesion molecule-1 in rat heart with ischetnia/reperfusion and limitation of infarct size by treatment with antibodies against cell adhesion molecules. Am J Pathol. 1993;143:410-418.
33. Winquist R, Frei P, Harrison P, McFarland M, Letts G, Van G, Andrews L, Rothlein R, Hintze T. Anti-CD 18 MAb limits infarct size in primates following myocardial ischemia and reperfusion. Circulation. 1990;82(suppl III):111-701. Abstract.
34. Williams FM, Kus M, Tanda K, Williams TJ. Effect of duration of ischaemia on reduction of myocardial infarct size by inhibition of neutrophil accumulation using an anti-CD18 monoclonal antibody. Br J Pharmacol. 1994;111:1123-1128.
35. Tanaka M, Brooks SE, Richards VJ, FitzHarris GP, Stoler RC, Jennings RB, Arfors KE. Effect of ami-CD18 antibody on myocardial neutrophil accumulation and infarct size after ischemia and reperfusion in dogs. Circulation. 1993;87:526-535.
36. Ma X-I, Tsao PS, Lefer AM. Antibody to CD-18 exerts endothelial and cardioprotective effects in myocardial ischemia and reperfusion. J Clin Invest. 1991;88:1237-1243.
37. Ma X-I, Lefer DJ, Lefer AM, Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation. 1992;86:937-946.
38. Rothlein R, Barton RW, Winquist R. The role of intercellular adhesion molecule-1 (ICAM-1) in inflammatory response. In: Cochrane CG, Gimbrone MA. eds. Cellular and Molecular Mechanisms of Inflammation. Orlando, Fla: Academic Press Inc: 1994:171-180.
39. Ioculano M, Squidrito F, Altavilla D, Canale P, Squidrito G, Campo GM, Saitta A, Caputi AP. Antibodies against intercellular adhesion molecule 1 protect against myocardial ischemia-reperfusion injury in rat. Eur J Pharmacol. 1994;264:143-149.
40. Goldberger A, Middleton KA, Oliver JA, Paddock C, Yan HC, DeLisser HM, Albelda SM, Newman PJ. Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form. J Biol Chem. 1994;269:17183-17191.
41. Yao Z, Foster PA, Gross GJ. Monophosphoryl lipid A protects against endotoxic shock via inhibiting neutrophil infiltration and preventing disseminated intravascular coagulation. Circ Shock. 1994; 43:107-114.
42. Brown JM, Grosso MA, Terada LS, Whitman GJR, Banerjee A, Whit CW, Harken AH, Ripine JE. Endotoxic pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc Natl Acad Sci USA. 1989;86:2516-2520.
43. Skoog WA, Beck WS. Studies on fibrinogen. dextran and phytohemagglutinin methods of isolating leukocytes. Blood. 1956;11:466-473.
44. Selye H, Bajusz E, Grasso S, Mendell S. A simple technique for the surgical occlusion of coronary vessels in the rat. Angiology. 1960; 11:398-407.
45. Knight B. Early myocardial infarction: practical methods for its postmortem demonstration. J Forensic Med. 1967;14:101-107.
46. Bradley PP, Priebat DA, Christensen RD, Rothstein GR. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206-209.
47. Mullane K, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods. 1985;14:157-167.
48. Griswold DE, Hillegrass LM, Hill DE, Egan JW, Smith EF. Method for quantification of myocardial infarction and inflammatory cell infiltration in rat cardiac tissue. J Pharmacol Methods. 1988;20: 225-231.
49. Kukielka GL, Hawkins HK, Michael LH. Regulation of intercellular adhesion molecule-1 (ICAM-I) in ischemic and reperfused canine myocardium. J Clin Invest. 1993;92:1504-1516.
50. Zimmerman GA, McIntyre TM, Mehra M, Prescott SM. Endothelial cell-associated platelet-activating factor: a novel mechanism for signalling intercellular adhesion, J Cell Biol. 1990;110:529-540.
51. Entman ML, Yourker K, Shappel SB, Siegel C, Rothlein R, Dreyer WJ, Schmalsteig GC, Smith CW. Neutrophil adherence to isolated adult canine myocytes: evidence for a CD 18-dependent mechanism. J Clin Invest. 1990;85:1497-1506.
52. Ko WA, Hawes AS, Lazenby WD, Calveno SE, Shin YT, Zelano JA, Antonacci AC. Platelet activating factor stimulates polymorpho-nuclear leukocyte hydrogen peroxide production during myocardial reperfusion. J Thorac Cardiovasc Surg. 1991;102:297-308.
53. Shappel SB, Toman C, Anderson DC, Taylor AA, Entman ML, Smith CW. Mac-1 (CD11b/CD18) mediated adherence-dependent hydrogen peroxide production by human and canine neutrophils. J Immunol. 1990;144:2702-2711.
54. Stahl GL, Terachita Z, Lefer AM. Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia. J Pharmacol Exp Ther. 1988;244:898-904.
55. Ma X-L, Weyrich AS, Krantz S, Lefer AM. Mechanisms of the cardioprotective action of WEB-2170, a platelet activating factor antagonist, in myocardial ischemia and reperfusion. J Pharmacol Exp Ther. 1992;260:1229-1236.
56. Lorant DE. Patel KD, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol. 1991;115:223-234.
57. Patel KD, Zimmerman GA, Prescott SM, McEver RP, McIntyre TM. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol. 1991;112:749-759.
58. Sako D, Chang XJ, Barone KM, Vachino G, White HM, Shaw G, Veldman GM, Bean KM, Ahern TJ, Furie B, Gumming DA, Larsen GR. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell. 1993;75:1179-1186.
59. Jolly SR, Kane WJ, Hook BG. Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. Am Heart J. 1986;112:682-690.
60. Litt MR, Jeremy RW, Weisman HF, Winkelstein JA, Becker LC. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia: evidence for neutrophil-mediated reperfusion injury. Circulation. 1989;80:1816-1827.
61. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 1983;67:1016-1023.